Yaochou Tsai | Health Professions | Best Researcher Award

Posted on by ScienceFather

Dr. Yaochou Tsai | Health Professions | Best Researcher Award

Investigator at Taipei Tzu Chi Hospital, Taiwan

Dr. Yao Chou Tsai, M.D., Ph.D., is a distinguished urologist and researcher, currently serving as the Director of the Department of Urology at Taipei Tzu Chi General Hospital and an Associate Professor of Urology. With expertise in robotic-assisted laparoscopic surgery, laparoendoscopic single-site surgery (LESS), and endourology, he has made significant contributions to urological research, particularly in Taiwan UTUC collaboration. Dr. Tsai has held various leadership roles, including Secretary General of the Taiwan Maple Urological Association and Scientific Committee member for prestigious international conferences. He has received numerous accolades, including the Young Investigator Award and multiple best surgical film awards. Actively involved in academia, he has delivered invited lectures and live surgical demonstrations worldwide. His work has been recognized for surgical excellence by the Symbol of National Quality. With a strong research and clinical background, Dr. Tsai continues to advance urological innovations, making him a leading figure

Professional Profile

Education

Dr. Yao Chou Tsai, M.D., Ph.D., has an extensive educational background in medicine and biomedical engineering. He earned his medical degree from Taipei Medical University (1990–1997), laying the foundation for his expertise in urology. Committed to advancing his knowledge, he pursued a Ph.D. in Biomedical Engineering at National Taiwan University (2011–2015), focusing on innovative surgical techniques and medical research. His post-graduate training includes a urology residency at National Taiwan University Hospital (1999–2003), where he gained specialized clinical experience. He further refined his skills through advanced training in laparoscopic and endoscopic surgery, including international workshops in Hong Kong and China. Dr. Tsai holds multiple board certifications, including those from the Taiwan Urological Association and Taiwan Association for Endoscopic Surgery. His robust education, combined with continuous professional development, has enabled him to become a leader in robotic surgery, laparoendoscopic techniques, and pediatric urology.

Professional Experience

Dr. Yao Chou Tsai, M.D., Ph.D., has a distinguished professional career in urology and minimally invasive surgery. Currently, he serves as the Director of the Department of Urology at Taipei Tzu Chi General Hospital and an Associate Professor of Urology. With over two decades of experience, he has held key leadership roles, including Deputy Director of the Medical Administration Office and Medical Department at Taipei Tzu Chi and Taipei Medical University Hospitals. He was also the Director of the Minimal Invasive Surgery Center and has played a crucial role in advancing robotic-assisted and laparoendoscopic single-site surgery (LESS). A recognized figure in the international urology community, Dr. Tsai has contributed as a scientific committee member for major urological conferences and serves on editorial boards of renowned medical journals. His expertise in research, clinical practice, and surgical education has positioned him as a leader in urological innovation and education worldwide.

Research Interests

Dr. Yao Chou Tsai, M.D., Ph.D., has a strong research focus on urological oncology, minimally invasive surgery, and robotic-assisted techniques. His work in Taiwan UTUC collaboration research has significantly contributed to the understanding and treatment of upper tract urothelial carcinoma (UTUC). He is also deeply involved in advancing robotic-assisted laparoscopic surgery and laparoendoscopic single-site surgery (LESS), improving surgical precision and patient outcomes. His expertise extends to endourology and pediatric urology, where he explores innovative techniques to enhance minimally invasive procedures. Dr. Tsai’s research has been recognized through numerous awards and publications, and he actively participates in international collaborations, sharing insights on cutting-edge surgical approaches. As an editorial board member of prestigious medical journals, he plays a key role in shaping the future of urological research. His dedication to surgical innovation and patient-centered research continues to make a lasting impact on the field of urology.

Awards and Honors

Dr. Yao Chou Tsai, M.D., Ph.D., has received numerous prestigious awards and honors in recognition of his contributions to urological surgery and research. His achievements include the Young Investigator Award at the 2008 World Congress of Endoscopic Surgery and multiple Best Surgical Film Awards from the Taiwan Urological Association. He has also been honored with several Medical Research and Publication Awards from Taipei Tzu Chi General Hospital, securing first, second, and third prizes across different years. In 2015, he received the Medical Contribution Award of New Taipei City, acknowledging his dedication to advancing medical practices. His surgical excellence was further recognized with the Symbol of National Quality (SNQ) Award for pioneering work in single-port endoscopic adrenalectomy. With his continuous contributions to minimally invasive and robotic-assisted surgery, Dr. Tsai remains a highly respected and awarded figure in the field of urology and medical innovation.

Research Skills

Dr. Yao Chou Tsai, M.D., Ph.D., possesses exceptional research skills in the field of urology, minimally invasive surgery, and robotic-assisted techniques. His expertise lies in clinical research, surgical innovation, and biomedical engineering, particularly in Taiwan UTUC collaboration research. He has a strong ability to design and conduct clinical trials, analyze surgical outcomes, and apply advanced statistical methods to evaluate treatment efficacy. Dr. Tsai is skilled in laparoendoscopic and robotic-assisted surgical techniques, contributing to the development of minimally invasive procedures that improve patient care. His proficiency in scientific writing and peer-reviewed publications has led to multiple research awards and international recognition. As an editorial board member of several medical journals, he is experienced in manuscript review, research ethics, and academic publishing. His ability to integrate clinical expertise with innovative research methodologies makes him a leader in urological advancements and medical technology development.

Conclusion

Dr. Tsai, Yao Chou is a highly accomplished researcher in urology, particularly in minimally invasive and robotic-assisted surgery. His academic leadership, numerous awards, and international recognition make him a strong candidate for the Best Researcher Award. Enhancing his research output in high-impact journals, securing major grants, and contributing to medical innovation would further strengthen his profile. However, based on his current credentials, he is highly deserving of this award.

Publication Top Notes

  • Tsai, Yaochou et al. (2025) – Diagnostic Accuracy of Indocyanine Green–stained Sentinel Lymph Nodes in Prostate Cancer Patients: A Systematic Review and Meta-analysis – European Urology Open Science

  • Tsai, Yaochou et al. (2025) – Re: Comparative Analysis of Holmium Laser Enucleation of the Prostate (HoLEP) and Robotic-Assisted Simple Prostatectomy (RASP) in BPH Management: A Systematic Review and Meta-Analysis – European Urology Focus

  • Tsai, Yaochou et al. (2024) – Central Pathology Review and its Prognostic Value in Upper Tract Urothelial Carcinoma Patients: A Nationwide Multi-Institutional Study – Scientific Reports

  • Tsai, Yaochou et al. (2024) – No Difference in Oncological Outcomes and Perioperative Complications Between Patients with ESRD with Unilateral and Bilateral UTUC Receiving Radical Nephroureterectomy – Scientific Reports

  • Tsai, Yaochou et al. (2024) – De Garengeot Hernia, an Acute Appendicitis in the Right Femoral Hernia Canal, and Successful Management with Transabdominal Closure and Appendectomy: A Case Report – BMC Urology – 1 citation

  • Tsai, Yaochou et al. (2024) – The Interplay Between von Hippel–Lindau Tumor Suppressor Gene, Lon Protease, ROS Accumulation, and Inflammation in Clear Cell Renal Cell Carcinoma – Current Issues in Molecular Biology

Mallar Bhattacharya | Medicine and Dentistry | Best Researcher Award

Posted on by ScienceFather

Dr. Mallar Bhattacharya | Medicine and Dentistry | Best Researcher Award

Associate Professor at UCSF, United States

Dr. Mallar Bhattacharya is an Associate Professor in Residence at the University of California, San Francisco (UCSF) in the Department of Medicine, Division of Pulmonary and Critical Care Medicine. With an extensive academic background, he earned his A.B. in Biology and Psychology from Harvard University, an M.Sc. in Neuroscience from Oxford University, and an M.D. from Harvard Medical School. His research focuses on lung fibrosis, acute lung injury, monocyte-derived macrophages, and cellular mechanisms in pulmonary diseases. Dr. Bhattacharya has received numerous honors, including the Will Rogers Institute Fellowship and recognition from the UCSF Bakar Aging Research Institute. He has served in leadership roles within the American Thoracic Society and as a reviewer for high-impact journals such as Nature, Cell, and Immunity. Actively engaged in both clinical practice and medical education, he mentors trainees and contributes to advancing critical care and pulmonary medicine through his research and teaching efforts.

Professional Profile 

Education

Dr. Mallar Bhattacharya has an extensive and prestigious academic background, reflecting his dedication to medical research and education. He earned his A.B. in Biology and Psychology from Harvard University, where he developed a strong foundation in the life sciences. He then pursued an M.Sc. in Neuroscience at Oxford University, gaining expertise in neurological and cellular mechanisms. Continuing his medical education, he obtained his M.D. from Harvard Medical School, one of the world’s leading institutions for medical training and research. His advanced studies equipped him with a deep understanding of pulmonary and critical care medicine, leading him to specialize in lung fibrosis, acute lung injury, and monocyte-derived macrophages. His academic journey has been marked by interdisciplinary learning, blending neuroscience, psychology, and medicine to advance pulmonary research. His education has provided the foundation for his contributions to medical science, clinical practice, and mentoring the next generation of researchers and physicians.

Professional Experience

Dr. Mallar Bhattacharya has built a distinguished career in pulmonary and critical care medicine, with a focus on research, clinical practice, and education. He serves as an Associate Professor at the University of California, San Francisco (UCSF), where he conducts groundbreaking research on lung fibrosis, acute lung injury, and monocyte-derived macrophages. As a practicing physician, he provides expert care to patients suffering from complex respiratory conditions, integrating the latest scientific advancements into clinical treatment. His leadership extends to mentoring medical students, residents, and fellows, shaping the next generation of researchers and clinicians. Dr. Bhattacharya’s work has been widely recognized through numerous grants and publications, contributing significantly to the understanding of pulmonary diseases. His commitment to academic medicine ensures that his research translates into meaningful medical advancements, improving patient outcomes and advancing the field of respiratory medicine. Through his work at UCSF, he continues to drive innovation in pulmonary research and treatment.

Research Interest

Dr. Mallar Bhattacharya’s research focuses on understanding the mechanisms underlying lung fibrosis, acute lung injury, and the role of immune cells in pulmonary diseases. His work explores how monocyte-derived macrophages contribute to lung inflammation and fibrosis, aiming to uncover novel therapeutic targets for conditions such as idiopathic pulmonary fibrosis (IPF) and acute respiratory distress syndrome (ARDS). By integrating molecular biology, immunology, and advanced imaging techniques, Dr. Bhattacharya investigates the cellular interactions that drive chronic lung disease progression. His research also delves into the signaling pathways that regulate immune responses in the lungs, with the goal of identifying strategies to modulate these pathways for improved treatment outcomes. Through his studies, he aims to bridge the gap between basic science and clinical application, ultimately translating laboratory discoveries into effective therapies. His contributions significantly enhance the understanding of pulmonary disease mechanisms and hold promise for developing targeted interventions in respiratory medicine

Award and Honor

Dr. Mallar Bhattacharya has been recognized with several prestigious awards and honors throughout his academic and professional career. During his undergraduate studies at Harvard College, he was consistently on the Dean’s List from 1994 to 1998 and was awarded the John Harvard Scholarship in 1995, 1997, and 1998 for his outstanding academic performance. In 1997, he was inducted into the Phi Beta Kappa Society, reflecting his exceptional scholarly achievements. He also received the New York State Robert C. Byrd Honors Scholarship during his time at Harvard. In 2000, Dr. Bhattacharya was honored with both the Pasteur Summer Research Fellowship for Medical Students and the American Neurological Association Summer Fellowship, supporting his early research endeavors. Later, in 2008-2009, he was awarded the Will Rogers Institute Fellowship, recognizing his contributions to pulmonary research. These accolades underscore Dr. Bhattacharya’s commitment to excellence in research and education.

Research Skill

Dr. Mallar Bhattacharya possesses a diverse set of research skills, particularly in the fields of pulmonary medicine, immunology, and fibrosis. His expertise includes advanced molecular and cellular biology techniques, allowing him to investigate complex disease mechanisms at a fundamental level. He is proficient in in vivo and in vitro models of lung disease, which he utilizes to explore the pathophysiology of pulmonary fibrosis and related conditions. Additionally, Dr. Bhattacharya has extensive experience in bioinformatics and data analysis, enabling him to interpret large datasets for translational research. His skill set also includes microscopy, flow cytometry, and genetic manipulation techniques, which he applies to study immune cell interactions in disease progression. Furthermore, his ability to integrate experimental findings with clinical insights enhances the impact of his research. Dr. Bhattacharya’s multidisciplinary approach and technical expertise contribute significantly to advancing scientific knowledge in lung disease and immune regulation.

Conclusion

Dr. Mallar Bhattacharya is a highly suitable candidate for the Best Researcher Award, given his cutting-edge research in pulmonary medicine, leadership in academia, and strong international reputation. His work on lung fibrosis and cellular immunity has significant translational potential. While additional landmark publications and broader leadership in global research initiatives would enhance his profile, his current contributions make him an outstanding contender for this award.

Publications Top Noted

  • Reference-based analysis of lung single-cell sequencing reveals a transitional profibrotic macrophage
    Authors: D Aran, AP Looney, L Liu, E Wu, V Fong, A Hsu, S Chak, RP Naikawadi, …
    Year: 2019
    Citations: 3461

  • Case 81: Antiphospholipid antibody syndrome with adrenal hemorrhage and Budd-Chiari syndrome
    Authors: M Bhattacharya, BM Yeh, A Qayyum, FV Coakley
    Year: 2005
    Citations: 310

  • Negative-pressure pulmonary edema
    Authors: M Bhattacharya, RH Kallet, LB Ware, MA Matthay
    Year: 2016
    Citations: 212

  • Impact of FDG PET on defining the extent of disease and on the treatment of patients with recurrent or metastatic breast cancer
    Authors: WB Eubank, D Mankoff, M Bhattacharya, J Gralow, H Linden, G Ellis, …
    Year: 2004
    Citations: 172

  • Absence of integrin αvβ3 enhances vascular leak in mice by inhibiting endothelial cortical actin formation
    Authors: G Su, A Atakilit, JT Li, N Wu, M Bhattacharya, J Zhu, JE Shieh, E Li, …
    Year: 2012
    Citations: 100

  • Molecular programs of fibrotic change in aging human lung
    Authors: S Lee, MN Islam, K Boostanpour, D Aran, G Jin, S Christenson, …
    Year: 2021
    Citations: 61

  • Immunology of human fibrosis
    Authors: M Bhattacharya, P Ramachandran
    Year: 2023
    Citations: 56

  • Globular domains 4/5 of the laminin α3 chain mediate deposition of precursor laminin 5
    Authors: RO Sigle, SG Gil, M Bhattacharya, MC Ryan, TM Yang, TA Brown, …
    Year: 2004
    Citations: 56

  • Invariant natural killer T cells coordinate removal of senescent cells
    Authors: S Arora, PJ Thompson, Y Wang, A Bhattacharyya, H Apostolopoulou, …
    Year: 2021
    Citations: 50

  • Counter regulation of spic by NF-κB and STAT signaling controls inflammation and iron metabolism in macrophages
    Authors: Z Alam, S Devalaraja, M Li, TKJ To, IW Folkert, E Mitchell-Velasquez, …
    Year: 2020
    Citations: 46

  • Effective treatment of mouse sepsis with an inhibitory antibody targeting integrin αvβ5
    Authors: G Su, A Atakilit, JT Li, N Wu, J Luong, R Chen, M Bhattacharya, …
    Year: 2013
    Citations: 37

Raj Ramesar | Medicine and Dentistry | Best Researcher Award

Posted on by ScienceFather

Prof. Raj Ramesar | Medicine and Dentistry | Best Researcher Award

Director: Research Unit at The University of Cape Town, South Africa

Prof. Raj Ramesar is a distinguished geneticist and researcher specializing in human genetics, genomics, and precision medicine. As Head of the Division of Human Genetics and Director of the MRC Genomics and Precision Medicine Research Unit at the University of Cape Town (UCT), he has made pioneering contributions to understanding the genetic basis of hereditary cancers, particularly familial colorectal cancer. His work has led to advancements in genetic testing, risk assessment, and clinical management, earning international recognition, including the Human Genome Organisation (HUGO) Africa Award and the UCT Vice-Chancellor’s Alan Pifer Award for Research Excellence. Prof. Ramesar has played a key role in developing genomic research infrastructure in Africa, collaborating on global initiatives, supervising numerous PhD theses, and advancing precision medicine applications. His research extends to inherited retinal disorders, contributing to clinical trials for genetic blindness treatments. His leadership continues to shape genomic medicine for public health benefits in Africa and beyond.

Professional Profile 

Education

Prof. Raj Ramesar obtained his academic and professional training in human genetics, laying a strong foundation for his contributions to medical genomics. He earned his Ph.D. in Human Genetics from the University of Cape Town (UCT), where he later became a leading academic and researcher. His postgraduate studies focused on the genetic basis of hereditary cancers and inherited disorders, which positioned him at the forefront of genomic medicine in Africa. Over the years, he has engaged in numerous advanced training programs and international collaborations, enhancing his expertise in precision medicine, genomic research, and bioinformatics. As an educator, he has mentored numerous postgraduate students and played a pivotal role in developing genetic research infrastructure in South Africa. His commitment to education extends beyond the university, as he actively participates in initiatives that promote genetic literacy and capacity-building in Africa. His academic journey reflects a deep commitment to advancing genetic research and education globally.

Professional Experience

Prof. Raj Ramesar is a distinguished geneticist with a career spanning several decades, primarily at the University of Cape Town (UCT). He serves as the Head of the Division of Human Genetics and the Department of Pathology at UCT and its affiliated hospitals.

SAMRC

Prof. Ramesar is also the Director of the South African Medical Research Council’s (SAMRC) Genomic and Precision Medicine Research Unit, where he leads research on the genetic underpinnings of inherited cancers and retinal degenerative disorders.

Institute of Development Management

His work has been instrumental in identifying novel genes and mutations within South African populations, with a recent focus on genetic studies in indigenous African communities. Beyond his research, he contributes to the scientific community by serving on editorial boards of international journals and holding leadership roles, including chairing the board of the Africa Genome Education Institute.

African Scientists

Prof. Ramesar’s professional journey reflects a steadfast commitment to advancing human genetics and improving health outcomes through precision medicine.

Research Interest

Prof. Raj Ramesar’s research interests primarily focus on human genetics, with a strong emphasis on hereditary cancers, inherited disorders, and genomic medicine. His work explores the genetic basis of diseases such as colorectal cancer and retinal dystrophies, aiming to develop early detection strategies and targeted therapies. He is deeply involved in precision medicine, leveraging genomic data to tailor healthcare solutions for diverse populations, particularly in Africa. His research also extends to bioinformatics, gene-environment interactions, and ethical considerations in genetic research. As a leader in African genomics, he is dedicated to addressing health disparities through genetic studies, fostering translational research that bridges the gap between laboratory discoveries and clinical applications. Additionally, he actively contributes to capacity-building initiatives, training researchers and clinicians in genomic methodologies. His work has significant implications for personalized medicine, public health policy, and the integration of genetic research into mainstream healthcare systems.

Award and Honor

Prof. Raj Ramesar, Head of the Division of Human Genetics at the University of Cape Town (UCT), has been honored with several prestigious awards recognizing his significant contributions to human genetics. In 2009, he received the UCT Vice-Chancellor’s Alan Pifer Award for his impactful research.

h3africa.org

In 2015, he was elected to the UCT College of Fellows, acknowledging his exceptional academic achievements.

ResearchGate

The following year, Prof. Ramesar was awarded the inaugural Africa Award by the Human Genome Organisation (HUGO) in recognition of his outstanding contributions to human genetics on the continent.

Health Sciences UCT

More recently, he was nominated for the NSTF-South32 Lifetime Award, further highlighting his enduring impact in the field.

Research Skill

Prof. Raj Ramesar possesses extensive research skills in human genetics, genomic medicine, and molecular biology. His expertise lies in identifying genetic markers associated with inherited diseases, particularly in the African population. He has mastered advanced genomic sequencing techniques, bioinformatics analysis, and molecular diagnostics to uncover genetic predispositions to conditions such as inherited cancers and retinal degenerative disorders. His research involves interdisciplinary collaboration, integrating clinical data with genetic insights to develop precision medicine approaches. Prof. Ramesar is highly skilled in genetic epidemiology, population genetics, and translational research, ensuring that scientific discoveries have practical healthcare applications. His ability to lead large-scale genomic studies, mentor young researchers, and contribute to global genetic research initiatives underscores his scientific acumen. He has also played a pivotal role in establishing genetic research frameworks in South Africa, promoting ethical research practices, and advancing the field of genomic medicine in Africa and beyond.

Conclusion

Dr. Rajkumar Ramesar is highly suitable for the Best Researcher Award. His outstanding contributions to human genetics, leadership in genomic research, and commitment to capacity-building in Africa make him a strong candidate. With his international recognition, innovative research, and dedication to precision medicine, he exemplifies the qualities of an award-winning researcher.

Publications Top Noted

  • Distinct Dysregulated Pathways in Sporadic and Lynch Syndrome‐Associated Colorectal Cancer Offer Insights for Targeted Treatment

    • Authors: May J. Krause, Musalula Sinkala, Raj Ramesar
    • Year: 2025
    • Citation: Krause MJ, Sinkala M, Ramesar R. Distinct Dysregulated Pathways in Sporadic and Lynch Syndrome‐Associated Colorectal Cancer Offer Insights for Targeted Treatment. FEBS Lett. 2025; DOI: 10.1002/1873-3468.70010.

  • Screening of Inherited Retinal Disease Patients in a Low‐Resource Setting Using an Augmented Next‐Generation Sequencing Panel

    • Authors: Nicole Midgley, George Rebello, Lara K. Holtes, Raj Ramesar, Lisa Roberts
    • Year: 2024
    • Citation: Midgley N, Rebello G, Holtes LK, Ramesar R, Roberts L. Screening of Inherited Retinal Disease Patients in a Low‐Resource Setting Using an Augmented Next‐Generation Sequencing Panel. Mol Genet Genomic Med. 2024; DOI: 10.1002/mgg3.70046.

  • Genomic Medicine in the Developing World: Cancer Spectrum, Cumulative Risk and Survival Outcomes for Lynch Syndrome Variant Heterozygotes with Germline Pathogenic Variants in the MLH1 and MSH2 Genes

    • Authors: Lutricia Ndou, Ramadhani Chambuso, Ursula Algar, Adam Boutall, Paul Goldberg, Raj Ramesar
    • Year: 2024
    • Citation: Ndou L, Chambuso R, Algar U, Boutall A, Goldberg P, Ramesar R. Genomic Medicine in the Developing World: Cancer Spectrum, Cumulative Risk and Survival Outcomes for Lynch Syndrome Variant Heterozygotes with Germline Pathogenic Variants in the MLH1 and MSH2 Genes. Biomedicines. 2024;12(12):2906. DOI: 10.3390/biomedicines12122906.

  • Influence of Genetic Polymorphisms on the Age at Cancer Diagnosis in a Homogenous Lynch Syndrome Cohort of Individuals Carrying the MLH1:c.1528C>T South African Founder Variant

    • Authors: Lutricia Ndou, Ramadhani Chambuso, Ursula Algar, Paul Goldberg, Adam Boutall, Raj Ramesar
    • Year: 2024
    • Citation: Ndou L, Chambuso R, Algar U, Goldberg P, Boutall A, Ramesar R. Influence of Genetic Polymorphisms on the Age at Cancer Diagnosis in a Homogenous Lynch Syndrome Cohort of Individuals Carrying the MLH1:c.1528C>T South African Founder Variant. Biomedicines. 2024;12(10):2201. DOI: 10.3390/biomedicines12102201.

  • Human Leukocyte Antigen-Allelic Variations May Influence the Age at Cancer Diagnosis in Lynch Syndrome

    • Authors: Lutricia Ndou, Ramadhani Chambuso, Ziyaad Valley-Omar, George Rebello, Ursula Algar, Paul Goldberg, Adam Boutall, Raj Ramesar
    • Year: 2024
    • Citation: Ndou L, Chambuso R, Valley-Omar Z, Rebello G, Algar U, Goldberg P, Boutall A, Ramesar R. Human Leukocyte Antigen-Allelic Variations May Influence the Age at Cancer Diagnosis in Lynch Syndrome. J Pers Med. 2024;14(6):575. DOI: 10.3390/jpm14060575.

  • Investigating Somatic Variants and Pathways in Mismatch Repair-Deficient (dMMR) Colorectal Carcinoma in South Africa

    • Authors: Aldera AP, van der Westhuizen J, Tsai W, Krause MJ, Yildiz S, Pillay K, Boutall A, Ramesar R
    • Year: 2024
    • Citation: Aldera AP, van der Westhuizen J, Tsai W, Krause MJ, Yildiz S, Pillay K, Boutall A, Ramesar R. Investigating Somatic Variants and Pathways in Mismatch Repair-Deficient (dMMR) Colorectal Carcinoma in South Africa. J Clin Pathol. 2024; DOI: 10.1136/jcp-2024-209526.

  • Towards Uncovering the Role of Incomplete Penetrance in Maculopathies through Sequencing of 105 Disease-Associated Genes

    • Authors: Hitti-Malin RJ, Panneman DM, Corradi Z, Boonen EGM, Astuti G, Dhaenens CM, Stöhr H, Weber BHF, Sharon D, Banin E, Raj Ramesar, et al.
    • Year: 2024
    • Citation: Hitti-Malin RJ, Panneman DM, Corradi Z, Boonen EGM, Astuti G, Dhaenens CM, Stöhr H, Weber BHF, Sharon D, Banin E, Ramesar R, et al. Towards Uncovering the Role of Incomplete Penetrance in Maculopathies through Sequencing of 105 Disease-Associated Genes. Biomolecules. 2024;14(3):367. DOI: 10.3390/biom14030367.

  • Human Leukocyte Antigen-Allelic Variations May Influence the Age at Cancer Diagnosis in Lynch Syndrome

    • Authors: Lutricia Ndou, Ramadhani Chambuso, Ziyaad Valley-Omar, George Rebello, Ursula Algar, Paul Goldberg, Adam Boutall, Raj Ramesar
    • Year: 2024
    • Citation: Ndou L, Chambuso R, Valley-O

Sanja Gluscevic | Medicine and Dentistry | Best Researcher Award

Posted on by ScienceFather

Dr. Sanja Gluscevic | Medicine and Dentistry | Best Researcher Award

Neurologist, MsC candidate, PhD candidate at Clinical centre of Montenegro, Montenegro

Dr. Sanja V. Gluscevic is a distinguished neurologist and medical professional based in Montenegro. She holds a medical degree from the University of Montenegro and completed her neurology residency at the University of Belgrade. Dr. Gluscevic has demonstrated significant leadership, serving as the first Montenegrin ambassador for neurology and brain health at the European Academy of Neurology, and as an ambassador for the Sumaira Foundation. She is also the founder of the Montenegrin Association for Brain Diseases, HOPE, and holds several prominent positions in clinical and educational settings, including teaching assistant roles and leadership in various medical organizations. Her extensive expertise spans multiple sclerosis, epilepsy, and other neurological conditions, with numerous publications in reputable medical journals. Dr. Gluscevic is actively involved in international collaborations and advocacy for neurological health, contributing to research, policy, and patient care advancements in Montenegro and beyond.

Professional Profile 

Education

Dr. Sanja V. Gluscevic’s educational background is rooted in both her medical and specialized neurological training. She completed her medical degree at the University of Montenegro, where she laid the foundation for her career in healthcare. Following her graduation, Dr. Gluscevic pursued advanced studies in neurology at the University of Belgrade, where she completed her neurology residency. During her education, she focused on various aspects of neurology, including the diagnosis and treatment of complex brain diseases such as multiple sclerosis and epilepsy. Beyond formal education, Dr. Gluscevic actively engaged in additional professional development through international training programs, conferences, and workshops, enhancing her expertise in neurology. Her academic achievements and continued commitment to learning have not only shaped her clinical career but have also fueled her contributions to neurological research, advocacy, and education, making her a prominent figure in the field of neurology in Montenegro and internationally.

Professional Experience

Dr. Sanja V. Gluscevic has an extensive professional background in neurology, making significant contributions to both clinical practice and research. She has worked at prominent medical institutions in Montenegro, providing exceptional care for patients with a wide range of neurological conditions, particularly focusing on multiple sclerosis, epilepsy, and neurodegenerative diseases. Her role as a neurologist includes diagnosing, treating, and managing chronic neurological disorders, offering personalized care to improve patient quality of life. Dr. Gluscevic has also been involved in various research initiatives, exploring innovative approaches to neurological treatments and working on projects aimed at enhancing the understanding of neurological diseases. She has participated in numerous international clinical trials and collaborated with research teams worldwide to bring new treatments to the forefront. Her leadership in the medical community extends to her involvement in educational programs, where she mentors and trains future neurologists, sharing her expertise and passion for advancing the field of neurology.

Research Interest

Dr. Sanja V. Gluscevic’s research interests primarily focus on the understanding and treatment of neurological disorders, with a particular emphasis on multiple sclerosis, epilepsy, and neurodegenerative diseases such as Alzheimer’s and Parkinson’s. Her research aims to uncover the underlying mechanisms of these diseases, exploring their pathophysiology and potential therapeutic strategies. She is particularly interested in the role of immune system dysfunction and neuroinflammation in the progression of neurological conditions. Dr. Gluscevic’s work also delves into the exploration of novel biomarkers for early diagnosis and monitoring disease progression. Additionally, she has been actively involved in clinical trials evaluating the efficacy of emerging treatments and pharmacological interventions. Through her research, Dr. Gluscevic strives to develop more effective, personalized treatment approaches to improve patient outcomes. Her contributions to the field of neurology aim to bridge the gap between laboratory findings and clinical applications, advancing both scientific knowledge and patient care.

Award and Honor

Dr. Sanja V. Gluscevic has received numerous prestigious awards and honors throughout her distinguished career, recognizing her contributions to the field of neurology and neuroscience. She has been acknowledged for her outstanding research in the areas of neurological diseases and neuroinflammation, particularly in relation to multiple sclerosis and neurodegenerative conditions. Among her accolades, Dr. Gluscevic has received research grants from prominent institutions, enabling her to further her investigations into innovative treatment strategies for neurological disorders. Her work has been recognized with invitations to present at international conferences, underscoring her status as a leading expert in the field. Dr. Gluscevic has also been awarded fellowships and awards for excellence in clinical research, contributing significantly to advancements in therapeutic development. Through these honors, she has gained widespread recognition for her pioneering research and her efforts to enhance patient care and scientific understanding of complex neurological diseases.

Research Skill

Dr. Sanja V. Gluscevic possesses a diverse and extensive skill set in research, which has greatly contributed to her success in the field of neurology and neuroscience. Her expertise includes a strong background in both basic and clinical research, with particular emphasis on neuroinflammation, neurodegeneration, and the pathophysiology of neurological disorders such as multiple sclerosis. Dr. Gluscevic is highly proficient in experimental design, utilizing a range of advanced techniques such as molecular biology, immunohistochemistry, and imaging technologies to investigate neurological processes at the cellular and molecular levels. She has a keen ability to translate laboratory findings into clinical applications, bridging the gap between experimental research and patient care. Additionally, her data analysis skills are complemented by her use of sophisticated computational tools for interpreting complex datasets. Dr. Gluscevic’s collaborative nature and leadership in interdisciplinary teams further enhance her ability to conduct innovative, high-impact research.

Conclusion

Sanja V. Gluscevic is a highly qualified candidate for the Best Researcher Award, demonstrating strong leadership, a diverse skill set, and a commitment to advancing research in neurology. Her publication record, advocacy work, and extensive experience in both education and clinical practice solidify her credentials. To further enhance her profile, expanding international collaborations and strengthening her impact on clinical practice would make her an even more formidable contender for the award. Overall, Gluscevic has proven herself to be a leading figure in her field, making significant contributions to both the research community and the broader healthcare landscape.

Publications Top Noted

  • Title: Long-term outcomes of infliximab treatment in neuro-Behcet syndrome: A single-center retrospective study
    Authors: Emine Rabia Koc, Gizem Güllü, Furkan Saridas, Sanja Gluscevic, Belkıs Coskun, Yavuz Pehlivan, Fatma Zehra Calikusu, Omer Faruk Turan
    Year: 2024
    Citation: Clinical Rheumatology, DOI: 10.1007/s10067-024-07198-7
  • Title: Long-term outcomes of infliximab treatment in neuro-Behcet syndrome: A single-center retrospective study
    Authors: Koc Emine Rabia, Güllü Gizem, Saridas Furkan, Gluscevic Sanja, Coskun Belkıs Nihan, Pehlivan Yavuz, Calikusu Fatma Zehra, Turan Omer Faruk
    Year: 2024
    Citation: Clinical Rheumatology, DOI: 10.1007/s10067-024-07118-9
  • Title: Sex-Specific Associations between Thyroid Status, Inflammation and Hemostasis Biomarkers in Patients with Subacute Thyroiditis
    Authors: Jelena Vekic, Aleksandra Klisic, Jelena Kotur-Stevuljevic, Neda Milinkovic, Sanja Gluscevic, Serpil Ciftel, Filiz Mercantepe
    Year: 2024
    Citation: Biomedicines, DOI: 10.3390/biomedicines12081862
  • Title: Cardiometabolic Risk Factors Related to Atrial Fibrillation and Metabolic Syndrome in the Pakistani Population
    Authors: Saira Rafaqat, Saima Shariif, Shagufta Naz, Sanja Gluscevic, Filiz Mercantepe, Ana Ninic, Aleksandra Klisic
    Year: 2024
    Citation: Medicina, DOI: 10.3390/medicina60081190

Özgür Kurt | Medicine and Dentistry | Best Researcher Award

Posted on by ScienceFather

Prof. Dr. Özgür Kurt | Medicine and Dentistry | Best Researcher Award

M.D. Ph.D. at ACIBADEM UNIVERSITY, Turkey

Prof. Dr. Özgür Kurt is a distinguished Professor of Medical Microbiology at Acibadem University, Turkey, with extensive expertise in parasitology and tropical diseases. He holds both an M.D. and a Ph.D. in Medical Parasitology, and has dedicated over two decades to advancing research and education in the field. His primary research interests focus on parasitic infections, microbiome studies, and the One Health approach. Dr. Kurt has led numerous high-impact research projects related to parasitic diseases, contributing to molecular diagnostic methods, treatment strategies, and the study of disease resistance. He has also been involved in medical education, teaching Medical Parasitology and Tropical Diseases at multiple medical schools in Turkey. In addition to his academic achievements, Dr. Kurt has demonstrated significant community involvement through voluntary healthcare provision in disaster-stricken areas, such as Turkey and Nepal. His contributions to science, education, and humanitarian work make him a leader in his field.

Professional Profile 

Education

Prof. Dr. Özgür Kurt’s academic journey reflects a strong foundation in medicine and parasitology. He completed his medical education at Ege University School of Medicine in Izmir, Turkey, graduating in 1997. Following this, he pursued advanced studies in medical parasitology at Celal Bayar University, where he earned his Ph.D. in 2006. His doctoral research focused on various aspects of parasitic diseases, laying the groundwork for his future research endeavors. Over the years, Dr. Kurt has further expanded his academic qualifications with additional training and professional development in medical microbiology. His commitment to education extends beyond his own studies, as he has taught Medical Parasitology and Tropical Diseases at multiple universities, including Acibadem University. His broad educational background, coupled with his deep specialization in parasitology and tropical diseases, has made him a prominent figure in the academic and scientific communities.

Professional Experience  

Prof. Dr. Özgür Kurt has a distinguished career in both clinical and academic settings. He began his professional journey as a research assistant at Celal Bayar University, where he worked in the Department of Parasitology from 1999 to 2006. He then transitioned to teaching and research roles at the same university, eventually advancing to Assistant and Associate Professor positions in the Department of Biology. In 2013, Dr. Kurt joined Acibadem University School of Medicine, where he became a Professor of Medical Microbiology, specializing in parasitic and tropical diseases. His expertise extends to medical microbiology, where he has been actively involved in both research and education. Dr. Kurt has also worked in clinical laboratory settings, including Acibadem LABMED Clinical Laboratories, and has been a consultant for tropical disease management at Acibadem Hospitals. Additionally, he has led several research projects funded by national and international organizations, focusing on parasitic infections, diagnostic methods, and disease resistance.

Research Interest

Prof. Dr. Özgür Kurt’s research interests focus on parasitic and tropical diseases, with a particular emphasis on their impact in the context of One Health. He explores various aspects of medical parasitology, including the epidemiology, diagnostics, and treatment of parasitic infections. A significant portion of his research involves investigating the role of eukaryotic organisms in the human microbiome, a relatively new and emerging field. Dr. Kurt is particularly interested in tropical diseases such as leishmaniasis, malaria, and amoebiasis, as well as the development of molecular diagnostic methods for detecting these infections. His work also extends to studying the resistance mechanisms of parasites to common treatments, as well as exploring novel therapeutic approaches. Additionally, he leads research projects on the vectors of diseases like leishmaniasis, focusing on the role of mosquitoes and sandflies. His extensive contributions aim to improve disease prevention, diagnosis, and treatment in both clinical and field settings.

Award and Honor

Prof. Dr. Özgür Kurt has received various awards and honors throughout his distinguished career, recognizing his significant contributions to the field of medical microbiology and parasitology. His expertise in tropical diseases and parasitic infections has earned him a reputation as a leading researcher in Turkey and internationally. Dr. Kurt has been acknowledged for his work in developing innovative diagnostic methods and treatments for parasitic diseases. He has received funding for numerous research projects from prestigious organizations, such as TÜBİTAK, and his research has been widely published in respected journals. His commitment to public health and his involvement in humanitarian efforts, including voluntary health care provision during major disasters in Turkey and Nepal, further highlight his dedication to science and society. Dr. Kurt’s ongoing contributions to medical education, clinical practice, and research continue to inspire future generations of scientists and healthcare professionals.

Conclusion

Dr. Özgür Kurt is a highly deserving candidate for the Best Researcher Award. His long-standing contributions to medical microbiology, particularly in parasitic and tropical diseases, have not only advanced scientific understanding but also improved public health outcomes. His academic excellence, leadership in research, and commitment to community service position him as a leader in the field. Strengthening his international collaborations and engaging in interdisciplinary research could further enhance his contributions to global health.

Publications Top Noted
  • Title: A possible link between subtype 2 and asymptomatic infections of Blastocystis hominis
    Authors: F Dogruman-Al, H Dagci, H Yoshikawa, Ö Kurt, M Demirel
    Year: 2008
    Citations: 168
  • Title: Molecular epidemiology of Blastocystis infections in Turkey
    Authors: M Özyurt, Ö Kurt, K Mølbak, HV Nielsen, T Haznedaroglu, CR Stensvold
    Year: 2008
    Citations: 165
  • Title: Toxoplasmosis in transplant recipients, Europe, 2010–2014
    Authors: F Robert-Gangneux, V Meroni, D Dupont, F Botterel, JMA Garcia, …
    Year: 2018
    Citations: 134
  • Title: Eradication of Blastocystis in humans: Really necessary for all?
    Authors: Ö Kurt, FD Al, M Tanyüksel
    Year: 2016
    Citations: 102
  • Title: Epidemiological and diagnostic features of Blastocystis infection in symptomatic patients in Izmir province, Turkey
    Authors: H Dagci, K Özgür, M Demirel, A Mandiracioglu, S Aydemir, SAZ Ulas, …
    Year: 2014
    Citations: 101
  • Title: Serological levels of zinc, copper and iron elements among Giardia lamblia infected children in Turkey
    Authors: P Ertan, K Yereli, Ö Kurt, IC BalcioĞlu, A OnaĞ
    Year: 2002
    Citations: 94
  • Title: Rural life, lower socioeconomic status and parasitic infections
    Authors: IC Balcioglu, Ö Kurt, ME Limoncu, G Dinç, M Gümüş, AA Kilimcioglu, …
    Year: 2007
    Citations: 83
  • Title: A comparison of metronidazole and single-dose ornidazole for the treatment of dientamoebiasis
    Authors: Ö Kurt, N Girginkardeşler, IC Balcioğlu, A Özbilgin, ÜZ Ok
    Year: 2008
    Citations: 80
  • Title: Preliminary virtual screening studies to identify GRP78 inhibitors which may interfere with SARS-CoV-2 infection
    Authors: A Palmeira, E Sousa, A Köseler, R Sabirli, T Gören, I Türkçüer, Ö Kurt, …
    Year: 2020
    Citations: 76
  • Title: Leishmaniasis in Turkey: Visceral and cutaneous leishmaniasis caused by Leishmania donovani in Turkey
    Authors: A Özbilgin, M Harman, M Karakuş, A Bart, S Töz, Ö Kurt, İ Çavuş, E Polat, …
    Year: 2017
    Citations: 75
  • Title: Endoplasmic reticulum stress markers in SARS-COV-2 infection and pneumonia: case-control study
    Authors: A Köseler, R Sabirli, T Gören, İ Türkçüer, Ö Kurt
    Year: 2020
    Citations: 69
  • Title: Leishmaniasis in Turkey: first clinical isolation of Leishmania major from 18 autochthonous cases of cutaneous leishmaniasis in four geographical regions
    Authors: A Özbilgin, G Çulha, S Uzun, M Harman, SG Topal, F Okudan, F Zeyrek, …
    Year: 2016
    Citations: 68